On the Frontlines of Multiple Sclerosis-logo

On the Frontlines of Multiple Sclerosis

ReachMD

Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis.

Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis.
More Information

Location:

United States

Networks:

ReachMD

Description:

Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis.

Language:

English


Episodes

Multiple Sclerosis in Pediatric & Pregnant Patients: Challenges in Treatment

7/31/2018
More
Host: David Weisman, MD Guest: Lauren Krupp, MD Guest: Prof. Ralf Gold MS is a challenging chronic disease to manage for any healthcare professional, but the most difficult cases we often face involve children and pregnant women. Up to 5% of people diagnosed with MS are under the age of 16. The peak age of diagnosis for women falls between 20 and 50 years old; however, that also happens to be the highest fertility window for these patients. Each of these populations present their own...

Duration:00:13:59

Disease Modifying Therapies in MS: Highlights from ACTRIMS 2018

2/23/2018
More
Guest: Thomas T. Leist, MD Guest: Clyde E. Markowitz, MD Multiple sclerosis is a quickly advancing field of medicine. The data presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting heavily focused on new and emerging concepts, including immune cell populations in the pathophysiology of MS. Join Dr. Thomas Leist and Dr. Clyde Markowitz as they review these advances. Disclaimer: Some products discussed in this activity have not received...

Duration:00:13:29

The New MS Treatment Landscape: Personalized Management Strategies

2/8/2018
More
Host: Matt Birnholz, MD Guest: Andrew Chan, MD Guest: Tobias Derfuss, MD Evolving treatment options in multiple sclerosis have ushered in a greater focus on providing personalized management to patients with multiple sclerosis. This interview will review the concept of NEDA (No Evidence of Disease Activity), and how its application using new treatment modalities has begun to improve patient outcomes. Join Professor Andrew Chan and Professor Tobias Derfuss as they explore the changing...

Duration:00:13:29

MS Pathogenesis: Understanding the Genetic & Environmental Triggers

12/15/2017
More
Host: Matt Birnholz, MD Guest: Gavin Giovannoni, MBBCh, PhD In this vital episode of On the Frontlines of Multiple Sclerosis, Dr. Matt Birnholz interviews Dr. Gavin Giovannoni, Professor of Neurology at Queen Mary University of London. Join us in examining the impact of genetic and environmental factors for MS, and how this information can influence MS diagnosis, management and treatment. This program has been brought to you through an independent educational grant from Merck KGaA,...

Duration:00:09:29

Addressing Employment Issues with MS Patients: Updates from the Ready for Work Project

10/2/2017
More
Host: Matt Birnholz, MD Guest: Antonella Cardone Antonella Cardone, Executive Director of the Fit for Work Global Alliance at the Work Foundation, joins Dr. Matt Birnholz on this powerful edition of On the Frontlines of Multiple Sclerosis. Ms. Cardone will be discussing the Ready for Work Project, which aims to promote positive work outcomes in clinical care with particular focus on improving access to treatment and employment support for all people living with MS. This project is a...

Duration:00:16:29

Improving Quality of Life for MS Patients Beyond the Exam Room: Strategies to Slow Disease Progression at Home

9/25/2017
More
Host: Jennifer Caudle, DO Guest: Jaume Sastre-Garriga, MD, PhD On this episode of On the Frontlines of Multiple Sclerosis, Dr. Jaume Sastre-Garriga, clinical neurologist and professor at the MS Center of Catalonia, joins Dr. Jennifer Caudle to provide recommended approaches for improving quality of life and slowing disease progression in patients with multiple sclerosis after they leave the exam room. This program has been brought to you through an independent educational grant from...

Duration:00:07:59

Emerging Concepts in the Management of MS: A Focus on T and B-Cell Targeting

7/28/2017
More
Host: Matt Birnholz, MD Guest: Andrew Chan, MD Professor Andrew Chan, Chief Physician, Deputy Clinical Director, Head of the Outpatient Neuro Center, and Head of the Neurological Policlinic at the University Hospital of Bern in Bern, Switzerland, joins Dr. Matt Birnholz on this special edition of On the Frontlines of Multiple Sclerosis. Professor Chan will be discussing the role of T and B cells in treating patients with multiple sclerosis, specifically when to employ these treatment...

Duration:00:11:29

Earlier Diagnoses for MS: Tools that Make the Biggest Patient Impacts

7/27/2017
More
Host: Matt Birnholz, MD Guest: Jiwon Oh, MD In this special edition of On the Frontlines of Multiple Sclerosis, Dr. Matt Birnholz speaks with Dr. Jiwon Oh, neurologist and Assistant Professor in the Department of Medicine at the University of Toronto, and scientist at the Keenan Research Center of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital in Toronto, Canada. They discuss the latest diagnostic tools available to clinicians, and the impact of early diagnosis on patient...

Duration:00:13:29

The Latest Therapies for MS: Weighing Respective Benefits and Risks

7/8/2017
More
Host: John J. Russell, MD Guest: Antonio Uccelli, MD In this special edition of On the Frontlines of Multiple Sclerosis, Professor Antonio Uccelli, Director of the Center of Excellence for Biomedical Research at the University of Genoa in Genoa, Italy joins host Dr. John Russell to discuss various treatment therapies for patients with multiple sclerosis, and the benefits and risks associated with these treatment options. This program has been brought to you through an independent...

Duration:00:14:59